Literature DB >> 22021698

Splenomegaly as risk factor of liver cirrhosis. A retrospective cohort study of 2,525 patients who underwent laparoscopy.

Rocco Orlando1, Flavio Lirussi, Stefano M M Basso, Franco Lumachi.   

Abstract

The aim of this study was to evaluate the meaning of laparoscopic splenomegaly and its relationship with the severity and evolution of liver cirrhosis. Medical records of 2,525 consecutive patients with chronic liver diseases who underwent laparoscopy and video-guided hepatic biopsy were reviewed. There were 1,610 (63.8%) men and 915 (36.2%) women. All patients underwent gastroscopy to diagnose esophageal varices. The diagnosis of cirrhosis was made in 910 (36.0%) patients, while 620 (24.6%) had hepatic fibrosis, and 995 (39.4%) chronic active hepatitis. Splenomegaly was present in 460 out of 910 patients (50.5%) with cirrhosis. Among the 1,615 patients without cirrhosis, splenomegaly was present in 80 (4.9%), and esophageal varices were present in 70 out of 910 (7.6%) cirrhotic patients. In patients without cirrhosis, esophageal varices were present in 30 out of 1,615 (1.2%) at the time of laparoscopy. Statistical analysis showed significant differences between patients with cirrhosis and without cirrhosis for splenomegaly (χ(2)=717.03, p<0.001) and esophageal varices (χ(2)=50.57, p<0.001). In conclusion, laparoscopic splenomegaly seems to be an important prognostic factor in liver cirrhosis, which represents a risk factor for portal hypertension.

Entities:  

Mesh:

Year:  2011        PMID: 22021698

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  8 in total

1.  Noninvasive methods for prediction of esophageal varices in pediatric patients with portal hypertension.

Authors:  Marina Rossato Adami; Cristina Targa Ferreira; Carlos Oscar Kieling; Vania Hirakata; Sandra Maria Gonçalves Vieira
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

Review 2.  Partial splenic artery embolization in cirrhotic patients.

Authors:  Tyson A Hadduck; Justin P McWilliams
Journal:  World J Radiol       Date:  2014-05-28

3.  Splenectomy versus Partial Splenic Embolization for Massive Splenomegaly Secondary to Hepatitis B-Related Liver Cirrhosis: A Case-Control Study.

Authors:  Shoufei Jiao; Hongxing Chen; Youlong Wang; Jiye Zhu; Jingwang Tan; Jie Gao
Journal:  Gastroenterol Res Pract       Date:  2016-06-22       Impact factor: 2.260

4.  Cirrhosis in Wilson Disease is characterized by Impaired Hepatic Synthesis, Leukopenia and Thrombocytopenia.

Authors:  Hao-Jie Zhong; Ping Xiao; Da Lin; Hui-Min Zhou; Xing-Xiang He
Journal:  Int J Med Sci       Date:  2020-05-29       Impact factor: 3.738

Review 5.  Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.

Authors:  James C Barton; J Clayborn Barton; Neha Patel; Gordon D McLaren
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

6.  Postoperative Outcomes Following a Modified Method of Surgical Division of the Splenic Pedicle in 719 Patients During Splenectomy for Portal Hypertension: A 12-Year, Retrospective, Single-Center Study.

Authors:  Long Huang; Qingsheng Yu; Hui Peng; Zhou Zhen
Journal:  Med Sci Monit       Date:  2022-08-30

7.  Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization.

Authors:  Takayuki Kogure; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Tooru Shimosegawa
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

8.  Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.

Authors:  Hao-Jie Zhong; Huan-Huan Sun; Lan-Feng Xue; Eileen M McGowan; Yu Chen
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.